Combination of atypical antipsychotics and NMDA modulators for the treatment of schizophrenia, bipolar disorder, cognitive impairment and major depressive disorder
The present disclosure features a combination of an NMDAR modulator and an atypical antipsychotic. The present disclosure provides a method of treating schizophrenia, bipolar disorder and / or cognitive impairment disease in a patient in need of treatment, including, for example, administering rapastine and an atypical antipsychotic. [Selection figure] None本開示は、ＮＭＤＡＲ調節剤及び非定型的抗精神病薬の組み合わせを特徴とする。本開示は、例えばｒａｐａｓｔｉｎｅｌ及び非定型的抗精神病薬を投与することを含む、例えば治療を必要とする患者の統合失調症、双極性障害及び／または認知障害疾患を治療する方法を提供する。【選択図】なし
